Premium
Nordson Corporation (NDSN)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Daniel R. HopgoodExec. VP & CFO | -148,00 | 41,63k | Sale to Issuer | 281,31 | 1,01k | -12,76% |
| 2025-12-29 | Mr. James E. DeVriesInitié | -1,25k | 0,00 | Other Disposition | - | 50,72k | -2,40% |
| 2026-04-16 | Mr. James E. DeVriesInitié | -198,00 | 54,51k | Sale to Issuer | 275,28 | 50,72k | -0,39% |
| 2026-04-17 | Mr. Srinivas SubramanianInitié | -1,20k | 336,00k | Automatic Disposition | 280,00 | 4,02k | -23,01% |
| 2026-04-17 | Mr. Srinivas SubramanianInitié | -1,90k | 327,47k | Derivative Exercise and Sale | 107,65 - 280,00 | 4,02k | - |
| 2026-04-15 | Dr. Milton M. MorrisIndependent Director | -245,00 | 67,10k | Vente | 273,87 | 1,83k | -11,78% |
| 2026-04-08 | Mr. Justin HallExec. VP of Medical & Fluid Solutions | -716,00 | 197,49k | Vente | 275,82 | 322,00 | -68,98% |
| 2026-02-27 | Ms. Sarah SiddiquiExec. VP & Chief HR Officer | -30,00 | 8,80k | Sale to Issuer | 293,44 | 2,26k | -1,31% |
| 2026-02-24 | Mr. Sundaram NagarajanPresident, CEO & Director | -41,80k | 5,35M | Derivative Exercise and Sale | 165,21 - 293,26 | 72,82k | - |
| 2026-02-23 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -29,47k | 2,87M | Derivative Exercise and Sale | 189,72 - 293,07 | 291,00 | - |
| 2026-02-23 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -2,31k | 669,42k | Vente | 289,00 - 295,26 | 291,00 | -88,81% |
| 2026-01-05 | Mr. Srinivas SubramanianInitié | -149,00 | 36,64k | Sale to Issuer | 245,89 | 5,21k | -2,78% |
| 2026-01-05 | Ms. Sarah SiddiquiExec. VP & Chief HR Officer | -117,00 | 28,77k | Sale to Issuer | 245,89 | 2,29k | -4,85% |
| 2026-01-05 | Mr. Sundaram NagarajanPresident, CEO & Director | -451,00 | 110,90k | Sale to Issuer | 245,89 | 72,70k | -0,62% |
| 2026-01-05 | Mr. James E. DeVriesInitié | -272,00 | 66,88k | Sale to Issuer | 245,89 | 53,68k | -0,50% |
| 2026-01-05 | Mr. Justin HallExec. VP of Medical & Fluid Solutions | -63,00 | 15,49k | Sale to Issuer | 245,89 | 1,04k | -5,74% |
| 2026-01-05 | Ms. Jennifer L. McDonoughExec. VP, General Counsel & Corporate Secretary | -391,00 | 96,14k | Sale to Issuer | 245,89 | 3,46k | -10,14% |
| 2026-01-05 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -561,00 | 137,94k | Sale to Issuer | 245,89 | 2,31k | -19,53% |
| 2025-12-19 | Mr. Daniel R. HopgoodExec. VP & CFO | -118,00 | 28,36k | Sale to Issuer | 240,38 | 645,00 | -15,47% |
| 2025-12-19 | Ms. Jennifer L. McDonoughExec. VP, General Counsel & Corporate Secretary | -107,00 | 25,72k | Sale to Issuer | 240,38 | 2,93k | -3,52% |
| 2025-12-19 | Mr. Justin HallExec. VP of Medical & Fluid Solutions | -18,00 | 4,33k | Sale to Issuer | 240,38 | 925,00 | -1,91% |
| 2025-12-19 | Mr. Srinivas SubramanianInitié | -59,00 | 14,18k | Sale to Issuer | 240,38 | 4,84k | -1,20% |
| 2025-12-19 | Mr. Sundaram NagarajanPresident, CEO & Director | -734,00 | 176,44k | Sale to Issuer | 240,38 | 67,39k | -1,08% |
| 2025-12-19 | Ms. Sarah SiddiquiExec. VP & Chief HR Officer | -95,00 | 22,84k | Sale to Issuer | 240,38 | 2,00k | -4,53% |
| 2025-12-19 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -208,00 | 50,00k | Sale to Issuer | 240,38 | 912,00 | -18,57% |
| 2025-12-19 | Mr. James E. DeVriesInitié | -308,00 | 74,04k | Sale to Issuer | 240,38 | 53,03k | -0,58% |
| 2025-12-01 | Mr. James E. DeVriesInitié | -213,00 | 50,06k | Sale to Issuer | 235,03 | 53,34k | -0,40% |
| 2025-12-01 | Ms. Jennifer L. McDonoughExec. VP, General Counsel & Corporate Secretary | -208,00 | 48,89k | Sale to Issuer | 235,03 | 2,80k | -6,92% |
| 2025-12-01 | Mr. Sundaram NagarajanPresident, CEO & Director | -1,42k | 334,45k | Sale to Issuer | 235,03 | 59,68k | -2,33% |
| 2025-12-01 | Ms. Sarah SiddiquiExec. VP & Chief HR Officer | -106,00 | 24,91k | Sale to Issuer | 235,03 | 1,89k | -5,32% |
| 2025-12-01 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -448,00 | 105,29k | Sale to Issuer | 235,03 | 653,00 | -40,69% |
| 2025-12-01 | Mr. Srinivas SubramanianInitié | -106,00 | 24,91k | Sale to Issuer | 235,03 | 4,70k | -2,21% |
| 2025-12-01 | Mr. Justin HallExec. VP of Medical & Fluid Solutions | -36,00 | 8,46k | Sale to Issuer | 235,03 | 943,00 | -3,68% |
| 2025-11-10 | Mr. James E. DeVriesInitié | -9,10k | 1,48M | Derivative Exercise and Sale | 70,91 - 233,60 | 53,55k | - |
| 2025-11-03 | Dr. Milton M. MorrisIndependent Director | -265,00 | 61,22k | Automatic Disposition | 231,00 | 2,08k | -11,31% |
| 2025-10-31 | Mr. James E. DeVriesInitié | -268,00 | 62,16k | Sale to Issuer | 231,95 | 53,55k | -0,50% |
| 2025-10-21 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -2,20k | 528,00k | Automatic Disposition | 240,00 | 92,00 | -95,99% |
| 2025-10-16 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -2,30k | 534,50k | Automatic Disposition | 232,39 | 2,29k | -50,09% |
| 2025-08-01 | Mr. Srinivas SubramanianInitié | -10,00 | 2,09k | Sale to Issuer | 209,25 | 4,41k | -0,23% |
| 2025-07-10 | Mr. Stephen F. ShamrockInitié | -1,18k | 262,89k | Other Disposition | 223,17 | 391,00 | -75,08% |
| 2025-07-10 | Mr. Stephen F. ShamrockInitié | -976,00 | 0,00 | Other Derivative Disposition | 209,73 - 238,80 | 0,00 | -100,00% |
| 2025-06-13 | Mr. Stephen P. LovassInitié | -79,00 | 16,75k | Sale to Issuer | 211,99 | 4,87k | -1,60% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
